Sagefield Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-13,800
Closed -$543K – 133
2023
Q2
$543K Buy
+13,800
New +$487K 0.12% 78

Sagefield Capital's ISEE Position: Q3 2023 in Review

Sagefield Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 13,800 shares — an estimated $543K sold.

Sagefield Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $543K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Sagefield Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Sagefield Capital sold 13,800 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $543K.
  • Sagefield Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Sagefield Capital's IVERIC bio, Inc. Common Stock position peaked at $543K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Sagefield Capital's 13F filing for Q3 2023, filed 14 Nov 2023.